| Prevalence and architecture of de novo mutations in developmental disorders Nature 542 (7642), 433-438, 2017 | 878 | 2017 |
| British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 RH McAllister-Williams, DS Baldwin, R Cantwell, A Easter, E Gilvarry, ... Journal of Psychopharmacology 31 (5), 519-552, 2017 | 225 | 2017 |
| Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review C McParlin, A O’Donnell, SC Robson, F Beyer, E Moloney, A Bryant, ... Jama 316 (13), 1392-1401, 2016 | 219 | 2016 |
| TUBA1A mutations cause wide spectrum lissencephaly (smooth brain) and suggest that multiple neuronal migration pathways converge on alpha tubulins RA Kumar, DT Pilz, TD Babatz, TD Cushion, K Harvey, M Topf, L Yates, ... Human molecular genetics 19 (14), 2817-2827, 2010 | 217 | 2010 |
| Histone lysine methylases and demethylases in the landscape of human developmental disorders V Faundes, WG Newman, L Bernardini, N Canham, J Clayton-Smith, ... The American Journal of Human Genetics 102 (1), 175-187, 2018 | 204 | 2018 |
| Cilia and disease L Eley, LM Yates, JA Goodship Current opinion in genetics & development 15 (3), 308-314, 2005 | 186 | 2005 |
| Expression analyses and interaction with the anaphase promoting complex protein Apc2 suggest a role for inversin in primary cilia and involvement in the cell cycle D Morgan, L Eley, J Sayer, T Strachan, LM Yates, AS Craighead, ... Human molecular genetics 11 (26), 3345-3350, 2002 | 185 | 2002 |
| Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant L Yates, M Pierce, S Stephens, AC Mill, P Spark, JJ Kurinczuk, M Valappil, ... Health Technol Assess 14 (34), 109-82, 2010 | 167 | 2010 |
| Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype LG Sadleir, EI Mountier, D Gill, S Davis, C Joshi, C DeVile, MA Kurian, ... Neurology 89 (10), 1035-1042, 2017 | 127 | 2017 |
| Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study H Fujii, A Goel, N Bernard, A Pistelli, LM Yates, S Stephens, JY Han, ... Neurology 80 (17), 1565-1570, 2013 | 113 | 2013 |
| Pregnancy outcome following maternal exposure to pregabalin may call for concern U Winterfeld, P Merlob, D Baud, V Rousson, A Panchaud, LE Rothuizen, ... Neurology 86 (24), 2251-2257, 2016 | 111 | 2016 |
| Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment A O’Donnell, C McParlin, SC Robson, F Beyer, E Moloney, A Bryant, ... Health Technology Assessment 20 (74), vii-268, 2016 | 101 | 2016 |
| Novel TMEM67 mutations and genotype‐phenotype correlates in meckelin‐related ciliopathies M Iannicelli, F Brancati, S Mougou‐Zerelli, A Mazzotta, S Thomas, ... Human mutation 31 (5), E1319-E1331, 2010 | 99 | 2010 |
| CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language L Snijders Blok, J Rousseau, J Twist, S Ehresmann, M Takaku, ... Nature communications 9 (1), 4619, 2018 | 96 | 2018 |
| The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants K Tatton-Brown, A Zachariou, C Loveday, A Renwick, S Mahamdallie, ... Wellcome open research 3, 2018 | 85 | 2018 |
| Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy AH O’Donnell-Luria, LS Pais, V Faundes, JC Wood, A Sveden, V Luria, ... The American Journal of Human Genetics 104 (6), 1210-1222, 2019 | 65 | 2019 |
| Determination of the mutation spectrum of the EXT1/EXT2 genes in British Caucasian patients with multiple osteochondromas, and exclusion of six candidate genes in EXT negative … L Lonie, DE Porter, M Fraser, T Cole, C Wise, L Yates, E Wakeling, E Blair, ... Human mutation 27 (11), 1160-1160, 2006 | 65 | 2006 |
| Prescribing without evidence–pregnancy SHL Thomas, LM Yates British journal of clinical pharmacology 74 (4), 691-697, 2012 | 60 | 2012 |
| Bi-allelic loss-of-function CACNA1B mutations in progressive epilepsy-dyskinesia KM Gorman, E Meyer, D Grozeva, E Spinelli, A McTague, A Sanchis-Juan, ... The American Journal of Human Genetics 104 (5), 948-956, 2019 | 58 | 2019 |
| Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation: The Deciphering Developmental Disorders Study JF McRae, S Clayton, TW Fitzgerald, J Kaplanis, E Prigmore, D Rajan, ... BioRxiv, 049056, 2016 | 51 | 2016 |
Sally stephensNewcastle UniversityVerified email at ncl.ac.uk
